Report Overview

The US Gastroesophageal Reflux Disease market stood at around USD XX million in 2019 and is estimated to reach USD XX million in 2028, exhibiting a CAGR of XX% in the forecast period

In the U.S., every year, more than 80 million people experience GERD symptoms, of which, 25 million people suffer from heartburn or acid reflux daily and 60 million people on a monthly basis. In addition, the number of outpatient clinic visits related to GERD in the U.S. has been increasing in the last few years stemming from the fact that the geriatric population is more prone to developing heartburn and acid reflux. Nearly 18% of the American population will be aged 65 and more by 2025.



Market Drivers

The US is expected to be the largest market owing to the presence of better healthcare infrastructure and the rising prevalence of GERD.